Back
Cyclacel Pharmaceuticals Vs. Viking Therapeutics Industry Stock Comparison
Sell
12
CYCC
Cyclacel Pharmaceuticals
Last Price:
1.65
Seasonality Move:
-15.51%
Sell
47
VKTX
Viking Therapeutics
Last Price:
52.96
Seasonality Move:
1.76%
Sell
12
Cyclacel Pharmaceuticals (CYCC)
is a Sell
Is Cyclacel Pharmaceuticals a Buy, Sell or Hold?
- The current Cyclacel Pharmaceuticals [CYCC] share price is $1.62. The Score for CYCC is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- CYCC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $52.96. The Score for VKTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYCC Stock Price Chart
What is Cyclacel Pharmaceuticals's stock price today?
-
The Cyclacel Pharmaceuticals share price today is $1.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYCC is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $52.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.
CYCC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 43.36 | Sell |
| Chaikin Money Flow: | -22554 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.63 - 2.13) | Sell |
| Bollinger Bands (100): | (1.81 - 2.55) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.9 | Sell |
| Relative Strength Index (14 RSI): | 43.41 | Sell |
| Chaikin Money Flow: | 113403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.34 - 60.74) | Sell |
| Bollinger Bands (100): | (47.23 - 79.29) | Sell |
CYCC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.67 | Sell |
| 20-day SMA: | 1.84 | Sell |
| 50-day SMA: | 2.01 | Sell |
| 200-day SMA: | 3.57 | Sell |
| 8-day EMA: | 1.7 | Sell |
| 20-day EMA: | 1.8 | Sell |
| 50-day EMA: | 1.98 | Sell |
| 200-day EMA: | 3.99 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.6 | Buy |
| 20-day SMA: | 53.66 | Sell |
| 50-day SMA: | 63.66 | Sell |
| 200-day SMA: | 39.18 | Buy |
| 8-day EMA: | 51.13 | Buy |
| 20-day EMA: | 54.21 | Sell |
| 50-day EMA: | 59.37 | Sell |
| 200-day EMA: | 45.7 | Buy |
Cyclacel Pharmaceuticals Earnings Growth & CYCC Earnings Dates
- Analysts estimate an earnings increase this quarter of $4.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.23 per share, and an increase next year of $0.61 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Cyclacel Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||